{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "State and local health officials began notifying about 400 American Media employees today that despite two blood tests analyzed by the federal Centers for Disease Control and Prevention, they could not definitively determine which of the workers had been exposed to anthrax. Therefore, anyone who spent an hour or more in the American Media building in Boca Raton in the two months ending Oct. 7 should consider themselves exposed and continue a 60-day regimen of Cipro antibiotics, the health officials told the workers.", "headline": {"main": "Workers Being Kept on Cipro After Tests Prove Inconclusive", "kicker": "A NATION CHALLENGED: THE FLORIDA CASES"}, "abstract": "State and local health officials in Florida begin notifying about 400 American Media employees that despite two blood tests analyzed by federal Centers for Disease Control and Prevention, they cannot definitely determine which of workers had been exposed to anthrax; say anyone who spent hour or more in American Media building in Boca Raton in two months ending Oct 7 should consider themselves exposed and continue 60-day regimen of Cipro antibiotics; building remains closed; photo (M)", "print_page": "6", "word_count": 480, "_id": "4fd24c4c8eb7c8105d7ebd79", "snippet": "State and local health officials began notifying about 400 American Media employees today that despite two blood tests analyzed by the federal Centers for Disease Control and Prevention, they could not definitively determine which of the workers had...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/10/27/us/nation-challenged-florida-cases-workers-being-kept-cipro-after-tests-prove.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "BOCA RATON (FLA)"}, {"name": "glocations", "value": "NEW YORK CITY"}, {"name": "glocations", "value": "FLORIDA"}, {"name": "glocations", "value": "WASHINGTON (DC)"}, {"name": "organizations", "value": "CENTERS FOR DISEASE CONTROL AND PREVENTION"}, {"name": "organizations", "value": "AMERICAN MEDIA INC"}, {"name": "subject", "value": "BIOLOGICAL AND CHEMICAL WARFARE"}, {"name": "subject", "value": "AIRLINES AND AIRPLANES"}, {"name": "subject", "value": "SHUTDOWNS (INSTITUTIONAL)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "HIJACKING"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "WORLD TRADE CENTER (NYC)"}, {"name": "subject", "value": "PENTAGON BUILDING"}, {"name": "subject", "value": "ANTHRAX"}, {"name": "subject", "value": "ANTIBIOTICS"}, {"name": "subject", "value": "CIPRO"}, {"name": "subject", "value": "TERRORISM"}, {"name": "subject", "value": "NEWS AND NEWS MEDIA"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Dana", "lastname": "CANEDY"}], "original": "By DANA CANEDY"}, "document_type": "article", "pub_date": "2001-10-27T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The rush to develop new vaccines and drugs to counter bioterrorism will pose another challenge: How should such drugs be tested so they can be approved for use? Normally, experimental drugs for diseases like cancer or arthritis are tested in clinical trials on people with the disease to see if the drugs are safe and effective. But there is no large group of people suffering from diseases like smallpox and anthrax, which are caused by pathogens that might be used by bioterrorists. And deliberately exposing people to lethal agents would be unethical.", "headline": {"main": "Rush for New Drugs Raises Questions About Testing", "kicker": "A NATION CHALLENGED: THE VACCINES"}, "abstract": "Rush to develop new vaccines and drugs to counter bioterrorism will pose challenge of how should such drugs be tested so they can be approved for use; normally, experimental drugs are tested in clinical trials on people with disease to see if drugs are safe and effective, but there is no large group of people suffering from diseases like smallpox and anthrax, which are caused by pathogens that might be used by bioterrorists; deliberately exposing people to lethal agents would be unethical; Dr Jane E Henney, former commissioner of Food and Drug Administration, comments; FDA is rushing to put into effect rule first proposed in late 1999 that would allow data from animal studies to be used in place of human testing when it is impossible or unethical to do tests on patients (M)", "print_page": "7", "word_count": 1096, "_id": "4fd211328eb7c8105d786462", "snippet": "The rush to develop new vaccines and drugs to counter bioterrorism will pose another challenge: How should such drugs be tested so they can be approved for use?     Normally, experimental drugs for diseases like cancer or arthritis are tested in...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/10/27/business/nation-challenged-vaccines-rush-for-new-drugs-raises-questions-about-testing.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "HENNEY, JANE E"}, {"name": "glocations", "value": "NEW YORK CITY"}, {"name": "glocations", "value": "WASHINGTON (DC)"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "BIOLOGICAL AND CHEMICAL WARFARE"}, {"name": "subject", "value": "WORLD TRADE CENTER (NYC)"}, {"name": "subject", "value": "AIRLINES AND AIRPLANES"}, {"name": "subject", "value": "VACCINATION AND IMMUNIZATION"}, {"name": "subject", "value": "ANTHRAX"}, {"name": "subject", "value": "PENTAGON BUILDING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "HIJACKING"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "TERRORISM"}, {"name": "subject", "value": "SMALLPOX"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2001-10-27T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Government health officials have taken the first step toward opening a second line of defense against anthrax in the form of a vaccine. Though the only well-known source of vaccine is a small stockpile owned by the Department of Defense, a large amount of new vaccine has been manufactured by BioPort, the sole maker. It is unavailable because the Food and Drug Administration has not yet approved BioPort's new plant or completed testing its vaccine lots, a company spokeswoman said.", "headline": {"main": "U.S. Moves Toward Making Anthrax Vaccine Available", "kicker": "A NATION CHALLENGED: THE PREVENTION"}, "abstract": "US Government health officials take first step toward opening second line of defense against anthrax in form of vaccine; though only well-known source of vaccine is small stockpile owned by Defense Department, large amount of new vaccine has been manufactured by BioPort, sole maker; it is unavailable because Food and Drug Administration has not yet approved BioPort's new plant or completed testing its vaccine in lots; agency can permit treatments on experimental basis; BioPort has been making anthrax vaccine since May 2000 and now has formidable amount; Defense Department owns all vaccine company makes, so it would also have to give permission for vaccine to be used (M)", "print_page": "7", "word_count": 651, "_id": "4fd2636f8eb7c8105d815d0e", "snippet": "Government health officials have taken the first step toward opening a second line of defense against anthrax in the form of a vaccine.    Though the only well-known source of vaccine is a small stockpile owned by the Department of Defense, a large...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/10/27/us/nation-challenged-prevention-us-moves-toward-making-anthrax-vaccine-available.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK CITY"}, {"name": "glocations", "value": "WASHINGTON (DC)"}, {"name": "organizations", "value": "BIOPORT CORP"}, {"name": "organizations", "value": "DEFENSE DEPARTMENT"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "BIOLOGICAL AND CHEMICAL WARFARE"}, {"name": "subject", "value": "WORLD TRADE CENTER (NYC)"}, {"name": "subject", "value": "AIRLINES AND AIRPLANES"}, {"name": "subject", "value": "VACCINATION AND IMMUNIZATION"}, {"name": "subject", "value": "ANTHRAX"}, {"name": "subject", "value": "PENTAGON BUILDING"}, {"name": "subject", "value": "HIJACKING"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "TERRORISM"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Nicholas", "lastname": "WADE"}], "original": "By NICHOLAS WADE"}, "document_type": "article", "pub_date": "2001-10-27T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "For decades, the United States' economic prescription to friend and foe was almost a mantra in its consistency: leave it to the market. State intervention was out. Subsidies were a nonstarter. Government should be limited, trade should be free, and regulation should be minimal.", "headline": {"main": "European Converts to Laissez Faire See the Rush to Intervene as Heresy"}, "abstract": "European Commission has been miserly, if not hostile, toward pleas for bailouts from European companies in wake of Sept 11 terrorist attacks, while US is spending billions to help airlines and is considering billions more for insurance companies; Bush administration and Congress want to jump-start American economy with new tax breaks and spending, but Europe's center-left governments have thus far avoided similar pump-priming (M)", "print_page": "1", "word_count": 1328, "_id": "4fd2636f8eb7c8105d815cd5", "snippet": "For decades, the United States' economic prescription to friend and foe was almost a mantra in its consistency: leave it to the market.    State intervention was out. Subsidies were a nonstarter. Government should be limited, trade should be free,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/10/25/business/european-converts-to-laissez-faire-see-the-rush-to-intervene-as-heresy.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "NEW YORK CITY"}, {"name": "glocations", "value": "EUROPE"}, {"name": "glocations", "value": "WASHINGTON (DC)"}, {"name": "organizations", "value": "EUROPEAN UNION"}, {"name": "subject", "value": "WORLD TRADE CENTER (NYC)"}, {"name": "subject", "value": "AIRLINES AND AIRPLANES"}, {"name": "subject", "value": "INSURANCE"}, {"name": "subject", "value": "TAXATION"}, {"name": "subject", "value": "UNITED STATES ECONOMY"}, {"name": "subject", "value": "PENTAGON BUILDING"}, {"name": "subject", "value": "HIJACKING"}, {"name": "subject", "value": "TERRORISM"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Alan", "lastname": "COWELL"}, {"firstname": "Edmund", "middlename": "L.", "lastname": "ANDREWS", "rank": 2, "role": "reported", "organization": ""}], "original": "By ALAN COWELL with EDMUND L. ANDREWS"}, "document_type": "article", "pub_date": "2001-10-25T00:00:00Z", "section_name": "Business"}], "meta": {"hits": 4, "offset": 0, "time": 31}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}